by Sunshine Biopharma | Aug 3, 2022 | Sec Filings
Available only in PDF version. Click HERE to...
by Sunshine Biopharma | May 22, 2022 | Sec Filings
Filed pursuant to Rule 424(b)(3)Under the Securities Act of 1933, as amendedRegistration No. 333-264830 Pursuant to this prospectus, the selling stockholders identified herein are offering on a resale basis an aggregate of 14,588,535 shares of common stock, par value...